Navigation Links
Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
Date:9/5/2007

. Yamamoto
Physical Review Letters (forthcoming)

It's hardly surprising that clinically depressed people act differently than healthy people. Quantifying the difference, however, can be difficult. Now a collaboration of physicists and psychiatrists in Japan has found a way to clearly and objectively measure depression.

The researchers outfitted both healthy control subjects and depressed patients with accelerometers to continuously measure their motions over 5-day periods. Although activity levels in all of the subjects followed power-law patterns (a type of distribution that often turns up in physics studies of natural systems) the activity levels of depressed patients were clearly distinguished from healthy subjects by a number known as the scaling parameter. For patients with major depression, the scaling parameter is significantly smaller than it is for healthy subjects.

It can be a challenge to spot differences in behavior between depressed and healthy individuals via simple observation, and self-reported depression assessments are often unreliable. Applying instrumentation and statistical analyses common in physics research could dramatically improve the reliability and accuracy in measurements of depression, and may help in tailoring appropriate treatments for the debilitating ailment.- JR


Pillar of Invisibility
Zhichao Ruan, Min Yan, Curtis W. Neff, and Min Qiu
Physical Review Letters (forthcoming)

While we are a long way off from the lightweight, high-performance, magical cloak of Harry Potter, Muggle physicists have been busy designing ways to make invisibility possible. A recent theoretical analysis of a column-shaped invisibility cloak, by a collaboration of researchers from Sweden and China, showed that a cloak made to ideal specifications could render an object (or wizard) hidden inside perfectly invisible. However, even slight deviations from these specification
'/>"/>

Contact: James Riordon
riordon@aps.org
301-919-2173
American Physical Society
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New method of measuring arterial stiffness in elderly hypertensives
2. Measuring Death Risk in COPD Patients
3. Measuring Exercise Capacity To Predict Heart Disease
4. A Novel Method For Measuring Interstitial Fluid Pressure In Cancer Tissues
5. Measuring disseminated cancer cells in bone marrow - valuable tool for detecting early breast cancer metastasis
6. Measuring Urinary Protein Helps In Detecting Recurrent Bladder Cancer
7. New Method For Measuring Dyskinesia In Parkinsons Being Developed
8. Measuring the Quantity of Information Passed on From the Eye to the Brain
9. Consumers way off the mark in measuring calorie content in fast foods
10. Hospital in New Zealand faces accusations for not measuring up
11. Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... and myeloproliferative disorders are serious and often deadly ... Annual Meeting of the American Society of Hematology ... methods for patients suffering from acute promyelocytic leukemia, ... myelofibrosis that are based on a better understanding ...
(Date:12/5/2009)... being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- ... without ever tying the knot, since research has shown that ... um, isn,t there something wrong with those who go it ... looking at psychological measures shows that never-married people aged 40 ...
(Date:12/5/2009)... innovative new international private medical insurance plan which follows the acclaimed ... the flexibility to add or remove a wide range of options ... tailor their benefits to complement those already offered in their country ... ...
(Date:12/5/2009)... to do everything from growing mushrooms, making wine to keeping prisoners in ... ... that your wine, water and vegetables would have come from Wind Turbines? ... turbines, for industry end users, not wind farms. "Using a technology ...
(Date:12/4/2009)... YORK, Dec. 4 Care Investment Trust Inc. (NYSE: ... its Board of Directors has declared a dividend of $0.17 per ... 22, 2009 to common shareholders of record on December 14, 2009. ... Care Investment Trust Inc. is a real estate investment and finance ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... Offers Fun and Wallet-Friendly Tips for Enjoying the ... makers of BENADRYL(R) and the National Park Foundation ... everyone, including people with allergies, to pledge to ... and family.(Photo: http://www.newscom.com/cgi-bin/prnh/20090420/NY01084 ...
... 25, 2009 BALTIMORE, April 20 The first annual ... gaining national support. The day is meant to raise ... the Meningococcal disease. "We recognize the dangers of meningitis ... said Fran Lessans, CEO of Passport Health, the largest ...
... Spring with Fresh, New Colors from Z-CoiL® , ... Albuquerque, NM (PRWEB) ... of our unique line of Pain Relief Footwear® products, ushers in spring ... Women. There is currently only a limited supply of these new athletic ...
... TOKYO, April 20 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., ... Kagaku Kenkyusho Co.,Ltd. (SKK), a pharmaceutical company headquartered ... into a strategic alliance. The partnership,was formed as ... SKK to target the,Asian market, in step with ...
... could prevent radiation-induced leukemia, according to data presented at ... 2009. , Alexandra Miller, Ph.D., a senior scientist ... research is designed to help military and space agency ... risky levels of radiation than the general population. However, ...
... can help control appetite and weight , , SUNDAY, April 19 ... on snacking by chewing more sugarless gum. , ... three hours after a standard lunch and were told they ... One afternoon the participants also chewed sugarless gum for 15 ...
Other Medicine News:Health News:The Makers of BENADRYL(R) and the National Park Foundation Encourage People to Pledge to Spend More Time Enjoying Outdoor Moments 2Health News:The Makers of BENADRYL(R) and the National Park Foundation Encourage People to Pledge to Spend More Time Enjoying Outdoor Moments 3Health News:The Makers of BENADRYL(R) and the National Park Foundation Encourage People to Pledge to Spend More Time Enjoying Outdoor Moments 4Health News:The Makers of BENADRYL(R) and the National Park Foundation Encourage People to Pledge to Spend More Time Enjoying Outdoor Moments 5Health News:First Annual World Meningitis Day Gaining National Support 2Health News:Got the Blues? Get Z-CoiL Pain Relief Shoes 2Health News:Shanghai ChemPartner and SKK Announce Strategic Alliance 2Health News:Gum Chewing May Cut Craving for Snacks 2
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... chemical threats, announced today that the Company is ... of Valortim® in an inhalation anthrax model in ... data are being presented during an oral session ...
(Date:12/4/2009)... HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced the ... by PennWell Corporation , a leader in ... dentistry. The course focuses on patient views ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented results ... of secondary end points of biochemical recurrence rate in ... for injection) or monthly leuprolide in prostate cancer patients ... patients who received FIRMAGON 240/80 mg/month had a recurrence ...
Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Mingling Martinis 26amp 3B Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 59087 1Mingling Martinis 26amp 3B Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 59087 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 1BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 3Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 1Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 2
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... Pacemaker Follow-Up Solution makes convenience and ... our Cardiac Monitoring Center, qualified professionals ... seven days a week for Pacemaker ... time they experience a problem or ...
Medicine Products: